Study of Metanx® in Subjects With Type 2 Diabetic Peripheral Neuropathy (DPN)

Clinical trial NCT00726713 · COMPLETED

Trial details

NCT number: NCT00726713
Sponsor: Pamlab, Inc.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Type 2 Diabetic Peripheral Neuropathy (DPN)

Start date: 2008-06-01
Primary completion: 2010-05-01
Enrollment: 214

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.